
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
Pharmacodynamics of RiaGev, a proprietary compound, demonstrate it efficiently increases NAD+ distribution throughout the body
April 2020
NAD is crucial for everyday health but decreases with age and certain conditions. RiaGev, a compound product containing nicotinamide and Bioenergy Ribose® directly enters the synthetic pathway. RiaGev appears to be more efficient than NR at increasing NAD+ throughout the body, including muscle and brain.

Upcoming webinars

The science of HMOs – A novonesis webinar featuring new clinical findings and ESPGHAN highlights
Novonesis
Register now

From boosters to companions: GLP-1 in Food, Beverages and Supplements
Rousselot
Register now

Aging Is Inevitable. Longevity Is Negotiable
Sabinsa
Register now
All upcoming webinars
Subscribe to our newsletters
By continuing to browse our site you agree to our Privacy Statement











